Stormer - I remember some time ago when the number of buyers >> sellers and you stating how it was irrelevant...because it is.
Mesoblast tanking has definitely had an impact on demand for biotech stocks. I do agree with you somewhat regarding the directors...I would like to see them buying up some stock to demonstrate they believe in the technology.
Cynata Therapeutics Ltd (ASX:CYP) Commentary on Industry News, page-44
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $58.84K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33236 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 163350 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |